Alemtuzumab Intravenous and Minocycline Extended-Release Capsules
Determining the interaction of Alemtuzumab Intravenous and Minocycline Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: minocycline
Brand name: Dynacin, Minocin, Minocin PAC, Minolira, Solodyn, Ximino, Vectrin, Myrac
Synonyms: Minocycline, Minocycline (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Minocycline Extended-Release Tablets
- Alemtuzumab Intravenous-Minocycline Hydrochloride
- Alemtuzumab Intravenous-Minocycline Hydrochloride eent
- Alemtuzumab Intravenous-Minocycline Hydrochloride Periodontal Microspheres
- Alemtuzumab Intravenous-Minocycline Injection
- Alemtuzumab Intravenous-Minocycline Intravenous
- Minocycline Extended-Release Capsules-Alenaze-D
- Minocycline Extended-Release Capsules-Alendronate
- Minocycline Extended-Release Capsules-Alendronate and cholecalciferol
- Minocycline Extended-Release Capsules-Alendronate Effervescent Tablets
- Minocycline Extended-Release Capsules-Alendronate Oral Solution
- Minocycline Extended-Release Capsules-Alendronate Sodium